company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q3,2010-07-01,2010-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,16453000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,16453000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,152000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-19215000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2610000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2610000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-135000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q3,2010-07-01,2010-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-135000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-135000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q3,2010-07-01,2010-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2745000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-29610000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-29610000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,384000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-479000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,22783000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6922000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6922000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-585000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,676000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,-1019000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q4,2010-10-01,2010-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-928000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-928000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofpreferredequity,Repurchase of Preferred Equity,+,debit,usd,-37000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,36000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q4,2010-10-01,2010-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7851000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 07:55:15+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5445000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 07:55:15+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5445000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 07:55:15+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,103000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 07:55:15+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,86000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 07:55:15+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,984000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 07:55:15+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4272000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 07:55:15+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4272000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 07:55:15+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-61000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 07:55:15+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-61000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 07:55:15+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-61000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 07:55:15+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,12500000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 07:55:15+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,9000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 07:55:15+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,12509000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 07:55:15+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,12509000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 07:55:15+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,8176000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q2,2011-04-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5560000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5560000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,114000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,8000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,269000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,273000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4896000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4896000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-153000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q2,2011-04-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-153000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-153000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-34000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,97000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,63000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,63000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q2,2011-04-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4987000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q3,2011-07-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6823000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6823000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,151000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,21000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,120000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3880000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2651000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2651000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-313000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q3,2011-07-01,2011-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-313000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-313000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q3,2011-07-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2964000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7478000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7478000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,666000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-29000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,417000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1654000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4770000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4770000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-156000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,50107000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q4,2011-10-01,2011-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,49951000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,49951000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,34000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,80000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,114000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,114000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-3000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q4,2011-10-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,45292000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:28:39+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7353000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:28:39+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7353000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:28:39+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,817000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:28:39+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,599000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:28:39+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-63000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:28:39+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6000000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:28:39+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6000000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:28:39+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-199000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:28:39+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-199000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:28:39+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-199000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:28:39+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,84600000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:28:39+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,286000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:28:39+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,84886000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:28:39+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,84886000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:28:39+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:28:39+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,78686000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q2,2012-04-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10223000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10223000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,851000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,913000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,8803000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,344000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,344000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-572000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q2,2012-04-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-572000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-572000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,173000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,173000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,173000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-4000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q2,2012-04-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-59000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10182000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10182000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1145000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1899000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4631000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11769000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11769000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1899000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-394000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q3,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2293000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2293000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,108136000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,474000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,108610000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,108610000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q3,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,94548000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15191000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15191000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1459000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,310000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1904000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1992000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13510000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13510000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1076000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-195365000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q4,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-196441000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-196441000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,428000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,428000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,428000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-209524000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 16:33:25+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14484000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 16:33:25+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14484000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 16:33:25+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1314000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 16:33:25+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,674000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 16:33:25+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1716000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 16:33:25+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6371000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 16:33:25+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-17151000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 16:33:25+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-17151000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 16:33:25+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2412000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 16:33:25+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-103776000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 16:33:25+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,43000000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 16:33:25+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-2868000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 16:33:25+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-66056000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 16:33:25+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-66056000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 16:33:25+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,111055000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 16:33:25+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2034000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 16:33:25+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,113089000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 16:33:25+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,113089000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 16:33:25+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-3000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 16:33:25+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,29879000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22107000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22107000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1344000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,643000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4370000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-253000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-16003000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-16003000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-5529000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-2500000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-58251000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,75700000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,9420000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,9420000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,190000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,396000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,586000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,586000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-5000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-6002000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-28123000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-28123000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1347000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,552000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2679000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,8092000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-15453000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-15453000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4373000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-64792000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,82750000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,13585000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,13585000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,170138000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,849000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,170987000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,170987000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-9000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,169110000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-30736000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-30736000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1561000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,617000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2922000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-759000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-26395000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-26395000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2307000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-199180000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,70500000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,933000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-130054000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-130054000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-190000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1880000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1690000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1690000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,26000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-154733000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:15:55+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-36424000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:15:55+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-36424000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:15:55+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1407000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:15:55+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,687000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:15:55+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3181000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:15:55+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2888000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:15:55+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-34037000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:15:55+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-34037000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:15:55+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3245000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:15:55+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-167577000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:15:55+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,90650000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:15:55+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,320000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:15:55+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-79852000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:15:55+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-79852000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:15:55+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,200925000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:15:55+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,3163000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:15:55+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,204088000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:15:55+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,204088000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:15:55+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-5000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:15:55+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,90194000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-50240000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-50240000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1743000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,953000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4245000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,7746000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-35553000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-35553000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-5632000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-4104000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-137181000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,95050000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-51867000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-51867000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,5555000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5555000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5555000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-13000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-81878000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-48319000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-48319000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1281000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1055000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6849000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-998000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-40132000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-40132000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-5159000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-109324000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,160500000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-536000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,45481000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,45481000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,789000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,789000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-54000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,6084000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-57665000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-57665000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1640000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1103000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,10159000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4361000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-40402000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-40402000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2730000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-2000000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-94150000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,140500000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,41620000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,41620000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4932000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4932000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-34000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,6116000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,2015-01-01,2015-03-31,2015-04-30 16:15:55+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-59601000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,2015-01-01,2015-03-31,2015-04-30 16:15:55+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-59601000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,2015-01-01,2015-03-31,2015-04-30 16:15:55+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1641000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,2015-01-01,2015-03-31,2015-04-30 16:15:55+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1491000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,2015-01-01,2015-03-31,2015-04-30 16:15:55+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7299000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,2015-01-01,2015-03-31,2015-04-30 16:15:55+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1727000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,2015-01-01,2015-03-31,2015-04-30 16:15:55+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-47443000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,2015-01-01,2015-03-31,2015-04-30 16:15:55+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-47443000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,2015-01-01,2015-03-31,2015-04-30 16:15:55+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1777000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,2015-01-01,2015-03-31,2015-04-30 16:15:55+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-385244000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,2015-01-01,2015-03-31,2015-04-30 16:15:55+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,136000000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,2015-01-01,2015-03-31,2015-04-30 16:15:55+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-251021000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,2015-01-01,2015-03-31,2015-04-30 16:15:55+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-251021000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,2015-01-01,2015-03-31,2015-04-30 16:15:55+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,308708000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,2015-01-01,2015-03-31,2015-04-30 16:15:55+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,5850000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,2015-01-01,2015-03-31,2015-04-30 16:15:55+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,314400000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,2015-01-01,2015-03-31,2015-04-30 16:15:55+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,314400000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,2015-01-01,2015-03-31,2015-04-30 16:15:55+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-12000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,2015-01-01,2015-03-31,2015-04-30 16:15:55+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,15924000.0
